Bristol-Myers Squibb’s $74 billion merger with Celgene went ahead this week after clearance from US competition regulators, and the focus has shifted on to whether Celgene shareholders will ...
Barrow's independent businesses are still reporting a brisk trade after Christmas despite a reported slump in UK Boxing Day shoppers. Early footfall data gathered by MRI Software indicated that ...